• 1. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 2. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 3. Aggregation behaviour of biocompatible choline carboxylate ionic liquids and their interactions with biomolecules through experimental and theoretical investigations?
  Somenath Panda,Kaushik Kundu,Anusha Basaiahgari,Sanjib Senapati,Ramesh L. Gardas New J. Chem., 2018,42, 7105-7118
• 4. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 5. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Aldehydes

Recent Advances in the Study of 2,6-Dichloro-3-hydroxybenzaldehyde (CAS: 56962-14-2) and Its Applications in Chemical Biology and Pharmaceutical Research

2,6-Dichloro-3-hydroxybenzaldehyde (CAS: 56962-14-2) is a key intermediate in the synthesis of various bioactive compounds, particularly in the fields of medicinal chemistry and chemical biology. Recent studies have highlighted its significance as a building block for the development of novel therapeutics, including antimicrobial, antifungal, and anticancer agents. This research briefing provides an overview of the latest advancements related to this compound, focusing on its synthetic applications, biological activities, and potential therapeutic uses.

One of the most notable developments in the study of 2,6-dichloro-3-hydroxybenzaldehyde is its role in the synthesis of Schiff base derivatives. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that Schiff bases derived from this aldehyde exhibit potent antimicrobial activity against drug-resistant bacterial strains, including MRSA. The researchers attributed this activity to the compound's ability to disrupt bacterial cell wall synthesis, making it a promising candidate for further drug development.

In addition to its antimicrobial properties, 2,6-dichloro-3-hydroxybenzaldehyde has been investigated for its potential in cancer therapy. A recent Bioorganic & Medicinal Chemistry Letters publication (2024) reported that derivatives of this compound show selective cytotoxicity against certain cancer cell lines, particularly those associated with breast and lung cancers. Mechanistic studies revealed that these derivatives induce apoptosis via the mitochondrial pathway, suggesting a novel mechanism of action that could be exploited for targeted cancer treatments.

The compound's unique chemical structure has also made it valuable in materials science applications. Researchers have utilized 2,6-dichloro-3-hydroxybenzaldehyde as a precursor for the synthesis of functionalized polymers with potential applications in drug delivery systems. A 2024 study in Polymer Chemistry described the development of pH-responsive polymeric nanoparticles incorporating this aldehyde, which demonstrated improved drug loading capacity and controlled release profiles compared to conventional systems.

From a synthetic chemistry perspective, recent advancements have focused on developing more efficient and environmentally friendly methods for producing 2,6-dichloro-3-hydroxybenzaldehyde. A green chemistry approach published in ACS Sustainable Chemistry & Engineering (2023) presented a microwave-assisted synthesis method that reduces reaction times and improves yields while minimizing hazardous waste generation. This development is particularly significant for scaling up production while adhering to increasingly stringent environmental regulations.

Looking forward, the versatility of 2,6-dichloro-3-hydroxybenzaldehyde continues to inspire innovative research across multiple disciplines. Current studies are exploring its potential in neurodegenerative disease research, with preliminary results indicating that certain derivatives may modulate pathways involved in Alzheimer's disease progression. As research progresses, this compound is likely to remain an important focus in the development of new therapeutic agents and functional materials in the chemical biology and pharmaceutical fields.

• 56962-11-9(2-Chloro-4-hydroxybenzaldehyde)
• 16861-22-6(2,3-Dichloro-4-hydroxybenzaldehyde)
• 56962-10-8(2-chloro-3-hydroxy-Benzaldehyde)
• 60964-09-2(2,6-Dichloro-4-hydroxybenzaldehyde)
• 54881-49-1(2-Chloro-3-methoxybenzaldehyde)
• 56962-12-0(4-Chloro-3-hydroxybenzaldehyde)
• 2314-36-5(3,5-Dichloro-4-hydroxybenzaldehyde)
• 152354-09-1(Benzaldehyde,2,5-dichloro-3,4-dihydroxy-)
• 156574-82-2(Benzaldehyde,2,6-dichloro-3,4-dihydroxy-)
• 7310-94-3(2-Chloro-5-hydroxybenzaldehyde)